Skip Navigation



Carcinogenesis Advance Access published online on September 30, 2004

Carcinogenesis, doi:10.1093/carcin/bgh289
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
26/1/201    most recent
bgh289v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pääjärvi, G.
Right arrow Articles by Högberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pääjärvi, G.
Right arrow Articles by Högberg, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received June 10, 2004
Revised September 8, 2004
Accepted September 17, 2004

CARCINOGENESIS

TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents

Gerd Pääjärvi 1, Matti Viluksela 2, Raimo Pohjanvirta 3, Ulla Stenius 1, and Johan Högberg 1*

1 Institute of Environmental Medicine, Karolinska Institutet, Box 210, 17177 Stockholm, Sweden
2 Laboratory of Toxicology, Department of Environmental Health, National Public Health Institute, FIN-70701 Kuopio, Finland
3 Department of Food and Environmental Hygiene, University of Helsinki, FIN-00014 Helsinki, Finland; National Veterinary and Food Research Institute, Kuopio, Finland

* To whom correspondence should be addressed. E-mail: johan.hogberg{at}imm.ki.se.


   Abstract

In this study we investigated the effect of TCDD on the p53 response to DNA damaging agents. Pretreatment of rats with TCDD attenuated the p53 liver response to diethylnitrosamine (DEN) and reduced levels of p53 and Ser15 phosphorylated p53. In addition, there were more slowly migrating p53 species, forming a ladder, which suggests an increased ubiquination of p53 in TCDD-pretreated rats. TUNEL analysis indicated decreased apoptosis rates in the livers of these rats. Studies on aryl hydrocarbon receptor (AhR) knockout mice and their wild-type littermates confirmed this effect in AhR +/+ but not in AhR -/- mice, indicating that this effect may be AhR-mediated. Quantitative RT-PCR analysis revealed no increased mRNA levels in TCDD-treated rats, but immunohistological studies indicated that TCDD modulated Mdm2 protein levels, and in particular, increased nuclear levels in rat hepatocytes in situ. In vitro studies employing HepG2 cells confirmed the in vivo data. Thus, TCDD increased basal levels of Mdm2 protein, but not mRNA, and attenuated the p53 response to a variety of genotoxic and cytotoxic agents. The increase in Mdm2 protein levels was accompanied by rapid and highly sensitive phosphorylation of Mdm2 at Ser166, which has been associated to active Mdm2. In summary, TCDD is a potent inhibitor of p53 that may influence the liver's ability to handle genotoxic agents in a safe way, and may play a role in TCDD-induced carcinogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Biswas, S. Srinivasan, H. K. Anandatheerthavarada, and N. G. Avadhani
Dioxin-mediated tumor progression through activation of mitochondria-to-nucleus stress signaling
PNAS, January 8, 2008; 105(1): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Malmlof, E. Roudier, J. Hogberg, and U. Stenius
MEK-ERK-mediated Phosphorylation of Mdm2 at Ser-166 in Hepatocytes: Mdm2 IS ACTIVATED IN RESPONSE TO INHIBITED Akt SIGNALING
J. Biol. Chem., January 26, 2007; 282(4): 2288 - 2296.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. R. Van Vleet, T. L. Watterson, P. J. Klein, and R. A. Coulombe Jr.
Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-Expressing Human Lung Cells
Toxicol. Sci., February 1, 2006; 89(2): 399 - 407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. Thomae, E. A. Stevens, and C. A. Bradfield
Transforming Growth Factor-{beta}3 Restores Fusion in Palatal Shelves Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
J. Biol. Chem., April 1, 2005; 280(13): 12742 - 12746.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.